Share on StockTwits

Novo Nordisk A/S (NYSE:NVO) posted its quarterly earnings results on Thursday. The company reported $0.48 earnings per share for the quarter, Stock Ratings reports.

On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Novo Nordisk A/S in a research note on Wednesday, July 23rd. They now have a $48.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Novo Nordisk A/S has an average rating of “Buy” and a consensus price target of $489.00.

Shares of Novo Nordisk A/S (NYSE:NVO) traded down 2.22% on Thursday, hitting $44.355. The stock had a trading volume of 850,050 shares. Novo Nordisk A/S has a 52-week low of $32.20 and a 52-week high of $48.42. The stock’s 50-day moving average is $45.87 and its 200-day moving average is $44.30. The company has a market cap of $117.2 billion and a price-to-earnings ratio of 26.30.

Novo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.